OrbiMed Capital GP V LLC, Director, 10% Owner at Compass Therapeutics, Inc. (CMPX), bought 216,071 shares at $1.56 ($339K) on 2022-05-09, disclosed to the SEC on 2022-05-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.63 | 10,200 | $17K | 4.9% |
| 2 | $1.56 | 90,712 | $142K | 41.8% |
| 3 | $1.56 | 90,712 | $142K | 41.8% |
| 4 | $1.60 | 24,447 | $39K | 11.5% |
| Total | $1.57 avg | 216,071 | $339K | 100% |
| Filing → |
| CRVS | SELL | 2021-09-22 | $13.5M | — | Filing → |
| ARPO | SELL | 2020-12-10 | $42K | — | Filing → |
| INSP | SELL | 2020-08-19 | $19.7M | — | Filing → |